Independent toxicological evaluation
Signed assessments of ingredient and finished-product safety. Hazard characterization, dose–response review, and uncertainty analysis structured for regulator and retailer scrutiny.
Independent scientific consulting · Exposure-based risk assessment
The Agyekum Group (AG) provides independent scientific consulting across cosmetics, personal care, consumer products, medical devices, pharmaceuticals, industrial chemicals, and environmental health. We deliver exposure-based risk assessment, toxicological evaluation, regulatory strategy, safety substantiation, and scientific governance to support product development, market access, regulatory compliance, and litigation.
The same exposure-based scientific methodology underpins every engagement, regardless of industry, product category, or regulatory framework. Our approach integrates toxicology, exposure science, risk assessment, and regulatory strategy to deliver scientifically defensible decisions across regulated industries.
Platform access available below.
Platform · supports the consulting practice
ToxIntel is Aᴳ’s enterprise scientific safety intelligence platform — a distinct product built to operationalize toxicological assessment, regulatory workflows, scientific governance, and product stewardship. It supports, but does not replace, the consulting practice.
Practice capabilities
Five practice areas anchor every engagement. Each is signed by a named toxicologist and documented for the next reader — regulator, retailer, or court.
Signed assessments of ingredient and finished-product safety. Hazard characterization, dose–response review, and uncertainty analysis structured for regulator and retailer scrutiny.
Quantitative SED / NOAEL / MoS / BMD analyses per population band. Pathway-specific exposure modelling for dermal, oral, inhalation, and mucosal use.
Product-level safety substantiation across cosmetics, personal care, fragrance, ingestibles, and adjacent consumer categories — fit for MoCRA, EU 1223, and IFRA contexts.
Toxicology-led regulatory strategy and litigation-aware documentation. Independent expert review, Prop 65 exposure framing, and enforcement-relevant scientific narrative.
Aᴳ’s in-house platform — contaminant surveillance, formulation review, compliance passport export, and continuously updated regulatory context. Made available to enterprise clients.
Federal Register, FDA, CPSC, OEHHA, and FTC signals tracked and interpreted — surfaced below in Toxicology Watch and integrated into client briefings.
Frameworks & methodology
Every Aᴳ evaluation references the same regulatory frameworks and scientific methodologies a competent authority, retailer, or court would reference. We are explicit about which framework applies, where its boundary lies, and what evidence the engagement produces.
Regulatory frameworks
Modernization of Cosmetics Regulation Act
U.S. cosmetic facility & product registration, adverse-event reporting, safety-substantiation evidence requirements.
Regulation (EC) No 1223/2009
Cosmetic Product Safety Reports (CPSR), responsible-person obligations, Annex II/III/IV/V/VI ingredient controls.
Safe Drinking Water and Toxic Enforcement Act
Exposure-based assessment vs Safe Harbor Levels; warning-decision logic; NSRL / MADL framing.
Regulation (EC) No 1907/2006
EU registration, evaluation, authorisation, and restriction of chemicals — hazard, exposure, and risk characterisation for substances placed on the EU market.
Regulation (EC) No 1272/2008
Classification, labelling, and packaging of substances and mixtures — hazard-class assignment, pictogram selection, and label composition per EU CLP.
OSHA HCS · UN GHS Purple Book
Hazard-communication classification, SDS authoring, and global-market label harmonisation via the Globally Harmonized System.
Biological evaluation of medical devices
Toxicological risk assessment, biological evaluation planning, and chemical-characterisation review — scientific support only, not certification.
Mutagenic impurities in pharmaceuticals
Nitrosamine and DNA-reactive impurity assessment, TTC-based control strategies, and PDE-derivation support for drug substances and products.
EU Scientific Committee on Consumer Safety
Authoritative EU opinions on cosmetic ingredients; SCCS Notes of Guidance methodology baseline.
International Fragrance Association
Fragrance-ingredient use restrictions, dermal sensitization QRA, category-specific limits.
Scientific frameworks
SED · MoS · BMD methodology
Quantitative dermal, oral, inhalation, and mucosal exposure modelling per population band.
NOAEL / LOAEL → MoS
Internal-dose modelling against point-of-departure values; uncertainty factor selection and justification.
Hazard characterization
Acute, subchronic, and chronic endpoint review across genotoxicity, sensitization, irritation, repro/dev, and systemic toxicity.
WoE evaluation
Structured integration of human, animal, in-vitro, and in-silico data streams with study-quality weighting.
Claim & label substantiation
Defensible documentation of safety, performance, and regulatory claims for retailer and litigation contexts.
All assessments are signed by a named toxicologist · documented for regulatory, retailer, and litigation contexts.
01 — Scope
Toxicology and risk assessment aligned with EU, FDA, and international frameworks where safety substantiation and exposure analysis are required.
Evaluation of formulations and ingredients against exposure-based safety criteria and documentation standards applied in retailer governance.
Independent toxicological analysis of chemical exposure, dose–response, causation, and complex data — structured to withstand legal scrutiny.
Hazard characterization, exposure considerations, and regulatory status review of ingredients in support of downstream use.
02 — Scientific practice
Aᴳ delivers scientific consulting across cosmetics, personal care, consumer products, pharmaceuticals, medical devices, industrial chemicals, and environmental toxicology. The same exposure-based methodology, board-certified oversight, and documentation discipline scales across every practice we engage.
ToxIntel is our enterprise scientific safety intelligence platform — a distinct product that operationalizes many of these workflows. It supports, but does not replace, the consulting practice.

01 · Practice
AvailableFoundational scientific assessment across every regulated category we serve.
Independent toxicological evaluation, exposure-based risk assessment, and defensible safety opinions — the scientific core of every Aᴳ engagement, regardless of product class.
Industries
Applicable regulations
Related ToxIntel capability

02 · Practice
AvailableScientific foundation of the practice
The scientific foundation the practice scales from.
Full-stack cosmetic and personal-care safety governance — from ingredient-level toxicology through Cosmetic Product Safety Reports, MoCRA readiness, and retailer compliance dossiers.
Industries
Applicable regulations
Related ToxIntel capability

03 · Practice
AvailableExposure-based safety governance beyond beauty.
Toxicological assessment for household, cleaning, air-care, pet, children’s, lifestyle, and wellness products — grounded in the same exposure-based methodology that powers our cosmetic practice.
Industries
Applicable regulations
Related ToxIntel capability

04 · Practice
Expert-led consultingExpert-led pharmaceutical toxicology and impurity science.
Consulting on pharmaceutical impurity risk, occupational exposure limits, nitrosamine assessment, and toxicological support for drug development. Expert-led — not automated software capabilities.
Industries
Applicable regulations
Related ToxIntel capability

05 · Practice
Expert-led consultingToxicological evaluation and biological-evaluation scientific support.
Expert-led toxicological evaluation, biological evaluation planning, and material risk assessment supporting medical-device programs. Scientific consulting only — we do not provide certification, notified-body services, or regulatory decisions.
Industries
Applicable regulations
Related ToxIntel capability

06 · Practice
AvailableCross-jurisdiction regulatory strategy grounded in defensible science.
Regulatory scientific consulting across chemistry, exposure, and hazard-communication frameworks — from California Prop 65 through REACH, CLP, and global GHS.
Industries
Applicable regulations
Related ToxIntel capability

07 · Practice
Expert-led consultingPersistence, bioaccumulation, and environmental exposure science.
Expert-led environmental risk assessment: PBT / vPvB / PMT screening, ecotoxicology review, and chemical persistence evaluation to support sustainable-formulation and stewardship decisions.
Industries
Applicable regulations
Related ToxIntel capability

08 · Practice
Expert-led consultingIndependent scientific review, evidence synthesis, and expert-witness support.
Literature reviews, weight-of-evidence assessments, scientific due diligence, and independent scientific review — for M&A diligence, litigation, and governance programs that require defensible scientific opinion.
Industries
Applicable regulations
Related ToxIntel capability
03 — Industries we serve
Aᴳ engages across the regulated categories where exposure-based safety assessment, defensible documentation, and independent scientific opinion carry commercial and regulatory consequence. The same scientific methodology scales across every category we serve.
04 — Scientific utilities
A public catalog of the scientific utilities the practice engages, organised by scientific domain. Each utility declares its status, its ToxIntel Enterprise module (where available), and the consulting service that supports it.
Items marked Available in ToxIntel Enterprise operate as fully-supported workflows inside the platform. Items marked Available through Scientific Consulting are delivered as expert-led engagements. Nothing in this catalog is exposed as an automated public calculator on this website.
Cosmetics & Personal Care
NOAEL → SED → MoS with population-band uncertainty factors and Aᴳ documentation trail.
Available in ToxIntel Enterprise
SED estimation from product concentration, dermal/oral/inhalation retention factors, and use frequency.
Available in ToxIntel Enterprise
Leave-on / rinse-off / mucosal pathway modelling with SCCS retention defaults.
Available in ToxIntel Enterprise
Map fragrance ingredients to IFRA use categories; identify applicable QRA limits.
Available through Scientific Consulting
Screen ingredient lists against restricted / monitored substances and Prop 65 markers.
Available in ToxIntel Enterprise
% w/w ↔ ppm ↔ mg/g conversions with formula-basis and dilution rounding.
Available through Scientific Consulting
Structured scenario capture: population, frequency, product form, retention, and pathway.
Available in ToxIntel Enterprise
Toxicological Risk Assessment
Structured toxicological risk assessment from hazard identification through characterization. Live via the Aᴳ /upload → assessment pipeline.
Available in ToxIntel Enterprise
Quantitative risk assessment with SED, Margin of Safety, and uncertainty documentation. Live via the Aᴳ full-QRA assessment pipeline.
Available in ToxIntel Enterprise
Combined exposure across multiple products / pathways for the same substance.
In beta inside ToxIntel Enterprise
Point-of-departure extraction and reference-value lookup with study-quality tagging.
Available in ToxIntel Enterprise
Side-by-side NOAEL / LOAEL / BMD / TTC candidates with justification capture.
In beta inside ToxIntel Enterprise
Interspecies / intraspecies / route / duration UF reference with justification prompts.
Available through Scientific Consulting
Structured WoE integration across human, animal, in-vitro, and in-silico data streams.
Available through Scientific Consulting
Pharmaceuticals
Permitted Daily Exposure derivation per EMA / ICH Q3D methodology.
Available through Scientific Consulting
OEL derivation and category-band screening for pharmaceutical manufacturing.
Available through Scientific Consulting
Structured nitrosamine impurity risk assessment aligned to EMA / FDA guidance.
Available through Scientific Consulting
DNA-reactive impurity classification, TTC / staged-limits, and control-strategy reasoning.
Available through Scientific Consulting
Structured qualification of API impurities across ICH Q3A/B/C with justification.
Available through Scientific Consulting
Medical Devices
Endpoint selection and evaluation-plan scaffolding per ISO 10993-1 categories.
Available through Scientific Consulting
Structured chemical characterization inventory: composition, extractables coverage, testing rationale.
Available through Scientific Consulting
E&L study-design planning across analytical thresholds, solvent selection, and reporting.
Available through Scientific Consulting
Category / type / duration classification decision-support per ISO 10993-1.
Available through Scientific Consulting
Toxicological risk planning aligned to ISO 14971 and biological-evaluation deliverables.
Available through Scientific Consulting
Environmental Toxicology
Persistence, bioaccumulation, toxicity screen per REACH Annex XIII criteria.
Available through Scientific Consulting
Very persistent / very bioaccumulative screen aligned to ECHA guidance.
Available through Scientific Consulting
Persistent / mobile / toxic screen for water-mobile contaminants.
Available through Scientific Consulting
Structured environmental exposure scenario capture (fate, release, receptor).
Available through Scientific Consulting
PEC / PNEC comparison and RCR workflow for aquatic and terrestrial endpoints.
Available through Scientific Consulting
Regulatory Science
Exposure-based Prop 65 screening: pathway estimates vs NSRL / MADL Safe Harbor Levels.
Available in ToxIntel Enterprise
Substance registration / evaluation / authorisation / restriction planning support.
Available through Scientific Consulting
Hazard-class assignment and pictogram checklist per EU CLP Regulation.
Available through Scientific Consulting
Globally Harmonized System label composition — signal words, pictograms, H/P statements.
Available through Scientific Consulting
Safety Data Sheet section-by-section planning aligned to REACH Annex II / OSHA HCS.
Available through Scientific Consulting
Scientific Intelligence
Structured PubMed / regulatory-agency search capture with query provenance.
Available through Scientific Consulting
Structured evaluation of study quality across design, endpoints, and reporting.
Available through Scientific Consulting
Klimisch-scale reliability classification (1–4) with justification prompts. Live via the Aᴳ Hazard Intelligence workspace.
Available in ToxIntel Enterprise
Systematic evidence mapping across ingredient, endpoint, and jurisdiction axes.
Available through Scientific Consulting
Chronological ingredient / regulatory / scientific evidence timeline for expert-witness contexts.
Available through Scientific Consulting
03 — Philosophy
Testing volume is increasing. The differentiator is not how much testing is performed — it is whether the data meaningfully reduces uncertainty and strengthens governance. Before recommending or reviewing any protocol, we define the decision:
04 — Practice lead
No anonymous reports, no offshored interpretation. Aᴳ is led personally by Dr. Augustine K. Agyekum, with specialist advisors engaged per assignment.

Founder · Independent Toxicologist
"Dr. Kwaku"
Founder of Aᴳ, an independent scientific consulting firm specialising in cosmetic and consumer product safety. Dr. Agyekum advises brands, manufacturers, and legal teams on ingredient safety, quantitative risk assessment, and compliance with FDA MoCRA, the EU Cosmetics Regulation, IFRA standards, and California Prop 65 — translating complex toxicological data into clear safety decisions.
Advisory roster
Aᴳ engages specialist advisors on a per-assignment basis — drawing on board-certified toxicologists, regulatory scientists, and analytical chemists when an engagement warrants additional depth. Roster details available on request.
05 — Engage
Send a short brief — product, jurisdictions, timeline, and the regulatory question that prompted the call. We respond within two business days.

Direct line
regulatory@tagc.us linkedin.com/company/the-agyekum-groupPractice
The Agyekum Group (AG)
Independent toxicology
Engagements
Cosmetics · Personal care
Ingestibles · Fragrance
Jurisdictions
EU · UK · US (FDA / MoCRA)
California Prop 65 · APAC
Platform
Platform Access →06 — Toxicology Watch
Aggregated from the public regulatory record — FDA, CPSC, EPA, OEHHA (California Proposition 65), the FTC, MHRA, OPSS (UK), and the U.S. Federal Register. Curated to surface the documents that meaningfully shape exposure, claim substantiation, and enforcement posture across cosmetics, personal care, consumer products, medical devices, pharmaceuticals, industrial chemicals, and environmental health.
Sources · FDA Cosmetics · CPSC · Proposition 65 · Consumer Protection · Cosmetics · Toxic Substances · Hazardous Materials · Environmental Protection · Medical Devices · UK Medicines & Devices · Drugs · Chemicals · EPA (agency-wide) · UK Office for Product Safety & Standards
This final rule updates the prospective payment rates for inpatient rehabilitation facilities (IRFs) for Federal fiscal year (FY) 2027. As required by statute, this final rule includes the classification and weighting…
Read sourceAll 10 Environmental Protection Agency (EPA) Regions are proposing for public comment the draft 2027 National Pollutant Discharge Elimination System (NPDES) general permit for stormwater discharges from construction…
Read sourceThis regulation establishes a tolerance for residues of permethrin (CASRN 52645-53-1) in or on the food and feed commodity of black pepper at 0.1 parts per million (ppm). Under the Federal Food, Drug, and Cosmetic Act…
Read sourceThe Federal Trade Commission granted early termination of its review of quantum computing developer IonQ Inc.’s proposed acquisition of SkyWater Technologies Inc., a quantum chip fabrication company.View Press Release
Read sourceList of manufacturers and their medical devices granted an exemption by MHRA. The list also includes manufacturers whose exemption expired or was cancelled.
Read sourceHow to join the phase I accreditation scheme.
Read sourceThe Environmental Protection Agency (EPA) is updating the materials that are incorporated by reference (IBR) into the Rhode Island State Implementation Plan (SIP). The regulations affected by this update have been…
Read sourceSummary of the latest safety advice for medicines and medical device users
Read sourceRelevant safety information for users of magnetic resonance imaging (MRI) equipment in clinical use.
Read sourceEPA is proposing significant new use rules (SNURs) under the Toxic Substances Control Act (TSCA) for certain chemical substances that were the subject of premanufacture notices (PMNs) and are also subject to an Order…
Read sourceFAA proposes to amend its commercial space licensing regulations to streamline the licensing process and reduce regulatory burden for applicants. Specifically, FAA proposes to invoke the Secretary of Transportation's…
Read sourceThe Environmental Protection Agency (EPA) is taking final action to approve a revision to the San Joaquin Valley Air Pollution Control District (SJVAPCD or "District") portion of the California State Implementation Plan…
Read sourceComplaint alleges telehealth provider shared consumers’ sensitive health information with third-party advertising platforms despite promising patient privacy The Federal Trade Commission, joined by Utah and California,…
Read sourceThe Food and Drug Administration (FDA) is classifying the phase-changing fiducial marker for radiation therapy into class II (special controls). The special controls that apply to the device type are identified in this…
Read sourceMemorandum of understanding between the Department for Business and Trade and United Kingdom Accreditation Service.
Read sourceInformation on OPSS product safety alerts, reports and recalls for unsafe products and resources for consumers, businesses and regulators.
Read sourceThe Department of Veterans Affairs (VA) is rescinding obsolete regulations that were previously implemented for the Veterans Choice Program, which has been replaced by the Veterans Community Care Program as of June 6,…
Read sourceThe U.S. Environmental Protection Agency (EPA or Agency) is finalizing an extension of certain compliance dates applicable to certain entities subject to the risk-management rules for perchloroethylene (PCE) and carbon…
Read sourceProposed order settling FTC allegations will require company and its executives to pay $300,000 and ban them from using unlawful tactics to bypass ticket purchase limits Ticket broker Elite Events and its operators will…
Read sourceThe U.S. Nuclear Regulatory Commission (NRC) is proposing to amend its regulations to reduce barriers to medical use licensing. This proposed rule responds to Executive Order 14300, "Ordering the Reform of the Nuclear…
Read sourceThe Food and Drug Administration (FDA) is classifying the active noise attenuation system for infant incubators into class II (special controls). The special controls that apply to the device type are identified in this…
Read sourceEPA is issuing a significant new use rule (SNUR) under the Toxic Substances Control Act (TSCA) for a certain chemical substance that was the subject of a premanufacture notice (PMN) and is also subject to an Order…
Read sourceThe Food and Drug Administration (FDA or we) is issuing an order to repeal the color additive regulation that allows for the use of Orange B for coloring the casings or surfaces of frankfurters and sausages. We have…
Read sourceEcosystem architecture
Authority
Independent scientific governance, toxicological evaluation, and regulatory interpretation — signed by a named toxicologist.
tagc.us
Enterprise infrastructure
Enterprise toxicology intelligence infrastructure — exposure assessment, contaminant surveillance, and compliance documentation for brands and retailers.
toxintel.tagc.usConsumer distribution
Consumer-facing distribution layer of the broader Aᴳ ecosystem. Operated and positioned separately from enterprise infrastructure.
getglowcheck.app